Literature DB >> 137074

The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice.

R J Carmel, J M Brown.   

Abstract

A study was made of the effect of various cytotoxic drugs on the ability of i.v.-injected KHT sarcoma cells to form lung colonies in syngeneic C3H mice. Some enhancement of the number of lung colonies following an i.v. injection was seen following pretreatment of the mice with actinomycin D and mithramycin, while pretreatment with vinblastine, bleomycin, methotrexate, cytosine arabinoside, or 5-fluorouracil had little or no effect on lung colony formation. Pretreatment of the mice with cyclophosphamide, however, greatly increased lung colony formation (by a factor of approximately 100). This enhancement in lung colony formation was maximal when the drug was given 24 hr prio to the injection of tumor cells, but was seen as early as 2 hr and persisted as long as 8 weeks prior to the tumor cell injection. The degree of enhancement of lung colony formation was related to the dose of cyclophosphamide and was present in weaning as well as adult mice. This enhancement was not significantly reversed by anticoagulation with either aspirin or warfarin. Immunosuppression by whole-body irradiation did not affect the number of lung colonies seen in cyclophosphamide-treated mice. The mechanism by which cyclophosphamide enhances metastatic tumor growth within the lung is not known. The major effect, however, does not appear to be mediated either by specific immunological or clotting factors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 137074

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death.

Authors:  Tsadik Habtetsion; Zhi-Chun Ding; Wenhu Pi; Tao Li; Chunwan Lu; Tingting Chen; Caixia Xi; Helena Spartz; Kebin Liu; Zhonglin Hao; Nahid Mivechi; Yuqing Huo; Bruce R Blazar; David H Munn; Gang Zhou
Journal:  Cell Metab       Date:  2018-06-07       Impact factor: 27.287

2.  YIGSR, a synthetic laminin peptide, inhibits the enhancement by cyclophosphamide of experimental lung metastasis of human fibrosarcoma cells.

Authors:  Y Iwamoto; Y Fujita; Y Sugioka
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

Review 3.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

Review 4.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

5.  Effect of a perfluorochemical emulsion on the development of artificial lung metastases in mice.

Authors:  S Rockwell; C G Irvin; M Nierenburg
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

6.  Preferential growth of metastatic tumors at the pleural surface of mouse lung.

Authors:  F W Orr; L Young; G M King; I Y Adamson
Journal:  Clin Exp Metastasis       Date:  1988 May-Jun       Impact factor: 5.150

7.  Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.

Authors:  Yingjen Jeffrey Wu; Leslie L Muldoon; Dana Thomas Dickey; Seth J Lewin; Csanad G Varallyay; Edward A Neuwelt
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

Review 8.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

9.  The effectiveness of cis-platinum, cyclophosphamide and melphalan in treating disseminated tumor cells in mice.

Authors:  A Kanclerz; J D Chapman
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

10.  Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma.

Authors:  Shuli Man; Yanjun Zhang; Wenyuan Gao; Lulu Yan; Chaoyi Ma
Journal:  Clin Exp Metastasis       Date:  2008-09-03       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.